Stay updated on ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe ZUMA-1 record for axicabtagene ciloleucel is displayed with its study design, participant criteria, locations, outcome measures, results, and supporting documents.SummaryDifference100%

- Check11 days agoChange DetectedThe site revision shown in the footer was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe revision marker in the footer changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error page with a minimal header and a Home button, replacing the expected study record content. This reflects an access-denied state rather than substantive changes to the study data or details.SummaryDifference25%

Stay in the know with updates to ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZUMA-1: KTE-C19 in Non-Hodgkin Lymphoma Clinical Trial page.